Jan 14, 2008 8:00am EST OPKO Health Appoints Industry Veteran Dr. Naveed Shams as Chief Medical Officer
Dec 06, 2007 8:00am EST OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials
Oct 30, 2007 9:49am EDT OPKO Health Acquires Rights to Innovative Ocular Product to Prevent Serious Eye Infections
Aug 30, 2007 10:55am EDT Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Jul 12, 2007 8:00am EDT Opko Health, Inc. Announces Early Termination of Hart-Scott-Rodino Waiting Period for Proposed Purchase of Shares by Dr. Phillip Frost